erhui1979 / iStockphoto.com

10 November 2017Biotechnology

LSIPR 50 2017: Steve Bates—Dreaming big for UK bioscience

From working as senior director at Genzyme to advising the UK government, Steve Bates has had a varied career, and he’s certainly no stranger to influencing public policy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Broad Institute wins appeal to restore CRISPR patent in Europe

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

WATCH: Section 112—Where has the dust settled?

UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung